News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Michael J. Fine, MD

Articles by Michael J. Fine, MD

Population Health Guide to the Evolution of Endpoints in Multiple Sclerosis

ByRobert Zivadinov, MD, PhD,Michael J. Fine, MD,Krishna R. Patel, PharmD, RPh,Neil Minkoff, MD

January 25th 2022

Effective and Efficient Diagnosis of Parkinsonism: The Role of Dopamine Transporter SPECT Imaging With Ioflupane I-123 Injection (DaTscanâ„¢)

ByJeffrey L. Cummings, MD, ScD,Michael J. Fine, MD,Igor D. Grachev, MD, PhD,C. Rick Jarecke, PharmD,Meridith K. Johnson, MSc,Phillip H. Kuo, MD, PhD,Joyce A. Oberdorf,Michael Rezak, MD, PhD,Da

March 24th 2014

Cost of Care for Malignant and Benign Renal Masses

ByAviva G. Asnis-Alibozek, PA-C,Michael J. Fine, MD,Paul Russo, MD,Trent McLaughlin, BSc(Pharm), PhD,Eileen M. Farrelly, MPH,Norman LaFrance, MD,William Lowrance, MD, MPH

August 12th 2013

Methods for better identifying malignant versus benign disease before nephrectomy could provide significant benefits to patients and payers.

Latest Updated Articles

Cost of Care for Malignant and Benign Renal Masses
Published: August 12th 2013 | Updated:
Effective and Efficient Diagnosis of Parkinsonism: The Role of Dopamine Transporter SPECT Imaging With Ioflupane I-123 Injection (DaTscanâ„¢)
Published: March 24th 2014 | Updated:

Trending on AJMC

TrumpRx Launch Brings Savings—and Uncertainty

How Do GLP-1 Agonists Fit Into Stroke Care?

5 Things to Know About the Oral GLP-1 Era

Addressing Disparities at Every Step of the Stroke Care Pathway: Luke Messac, MD, PhD

Stroke Subtype Does Not Affect Efficacy of Asundexian for Second Stroke Prevention

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.

Alt Text

Alt Text